ReachMD

Popular

• • 

    

    Cassandra B. Donnelly, DO

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  2

  

  RestartResume

  Act Fast: A Case Study on Post-Exposure Influenza Prophylaxis

  Act Fast: A Case Study on Post-Exposure Influenza Prophylaxis

  0.25 credits
• 0

  

  RestartResume

  Keys to Helping Overcome the Growing Prevalence of Peripheral Artery Disease

  Keys to Helping Overcome the Growing Prevalence of Peripheral Artery Disease

• • 

    

    Arjun V. Balar, MD

    Peer

  • 

    

    Daniel P. Petrylak, MD

    Peer

  0

  

  RestartResume

  State of the Union: Advances in the Management of mUC

  State of the Union: Advances in the Management of mUC

  0.50 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Michelle Y. Owens, MD

    Peer

  4

  

  RestartResume

  Counseling Your Patients At Risk of HDFN

  Counseling Your Patients At Risk of HDFN

  0.25 credits

• • 

    

    Maria E. Arcila, MD

    Peer

  • 

    

    Alexander Drilon, MD

    Peer

  0

  

  RestartResume

  Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments

  Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments

  1.00 credits

• • 

    

    Diana Do, MD

    Peer

  • 

    

    Nancy M. Holekamp, MD

    Peer

  • 

    

    Carl Regillo, MD

    Peer

  1

  

  RestartResume

  On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME

  On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME

  0.50 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  3

  

  RestartResume

  Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders

  Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders

  0.25 credits

• • 

    

    Jay Raman, MD, FACS

    Peer

  • 

    

    Oguz Akin, MD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  • 

    

    Elizabeth Plimack, MD, MS

    Peer

  0

  

  RestartResume

  RCC Treatment Strategies in a Favorable-Risk Patient

  RCC Treatment Strategies in a Favorable-Risk Patient

  0.50 credits

• • 

    

    Cheryl Pirozzi, MD, MS

    Peer

  • 

    

    Charlie Strange, MD

    Peer

  1

  

  RestartResume

  Recognizing & Treating Alpha-1 Antitrypsin Deficiency (AATD)

  Recognizing & Treating Alpha-1 Antitrypsin Deficiency (AATD)

  1.00 credits

• • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Alberto Augsten, PharmD

    Peer

  0

  

  RestartResume

  Combating the Crippling Rise of Alcohol Dependency Amid COVID-19

  Combating the Crippling Rise of Alcohol Dependency Amid COVID-19

• • 

    

    Arlene B. Chapman, MD

    Peer

  • 

    

    Michel Chonchol, MD

    Peer

  0

  

  RestartResume

  Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies

  Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies

  0.50 credits
• 0

  

  RestartResume

  A Molecular Deep Dive Into BRAF-Mutant Colorectal Cancer

  A Molecular Deep Dive Into BRAF-Mutant Colorectal Cancer

• • 

    

    Garth W. Garrison, MD

    Peer

  • 

    

    Prema Menon, MD, PhD

    Peer

  0

  

  RestartResume

  Emerging Treatment Strategies for the Management of Patients with Chronic Cough

  Emerging Treatment Strategies for the Management of Patients with Chronic Cough

  1.00 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  2

  

  RestartResume

  A New Normal? COVID-19 and HF in Clinical Trials

  A New Normal? COVID-19 and HF in Clinical Trials

  0.25 credits

• • 

    

    Tracey Evans, MD

    Peer

  • 

    

    Raja Mudad, MD

    Peer

  2

  

  RestartResume

  Patient Case Study: A First-Line Treatment Approach in Extensive-Stage Small Cell Lung Cancer

  Patient Case Study: A First-Line Treatment Approach in Extensive-Stage Small Cell Lung Cancer